{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:23:36Z","timestamp":1765545816397},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.pbb.2013.01.010","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T16:51:00Z","timestamp":1359737460000},"page":"12-16","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): An experimental study"],"prefix":"10.1016","volume":"105","author":[{"given":"Pelin","family":"Tanyeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Emin","family":"Buyukokuroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguz","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcner","family":"Ulak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00fcruzan","family":"Y\u0131ld\u0131z Akar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ipek","family":"Komsuoglu Celikyurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bekir Faruk","family":"Erden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2013.01.010_bb0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1192\/bjp.172.6.465","article-title":"Serotonin and panic","volume":"172","author":"Bell","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.010_bb0010","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1476-5381.1990.tb14100.x","article-title":"In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon","volume":"100","author":"Bianchetti","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.010_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/026988110201600112","article-title":"Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat","volume":"16","author":"Blokland","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2011.02.039","article-title":"Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems","volume":"658","author":"Bruning","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pbb.2013.01.010_bb0030","first-page":"252","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J Psychiatry Neurosci"},{"issue":"2","key":"10.1016\/j.pbb.2013.01.010_bb0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuroscience.2008.07.011","article-title":"Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant\/anxiolytic-like profile","volume":"156","author":"Claustre","year":"2008","journal-title":"Neuroscience"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2013.01.010_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2007.06.048","article-title":"Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant\/anxiolytic drugs?","volume":"573","author":"Consoli","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0959-4388(99)80032-4","article-title":"Regional brain function, emotion and disorders of emotion","volume":"9","author":"Davidson","year":"1999","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/(SICI)1096-8628(20000207)96:1<56::AID-AJMG12>3.0.CO;2-L","article-title":"Association of polymorphism of serotonine 2A receptor gene with suicidal ideation in major depressive disorder","volume":"96","author":"Du","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pbb.2013.01.010_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1054\/mehy.2000.1187","article-title":"An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap","volume":"56","author":"Dursun","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pbb.2013.01.010_bb0065","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.2570461","article-title":"Molecular characterization of the human beta 3-adrenergic receptor","volume":"245","author":"Emorine","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pbb.2013.01.010_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1476-5381.1996.tb15176.x","article-title":"Expression of beta 3-adrenoceptor mRNA in rat tissues","volume":"117","author":"Evans","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1152\/physrev.1983.63.2.484","article-title":"Role of precursor availability in control of monoamine biosynthesis in brain","volume":"63","author":"Fernstrom","year":"1983","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pbb.2013.01.010_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(95)00234-C","article-title":"A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY 100635","volume":"281","author":"Forster","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pbb.2013.01.010_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2010.05.003","article-title":"Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: \u0131nvolvement of serotonergic system","volume":"59","author":"Gay","year":"2010","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2013.01.010_bb0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2012.02.034","article-title":"Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice","volume":"682","author":"Girisch","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1432-1033.1994.00761.x","article-title":"Antibodies for the immunochemistry of the human beta 3-adrenergic receptor","volume":"224","author":"Guillaume","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pbb.2013.01.010_bb0110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1124\/jpet.102.048249","article-title":"Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan","volume":"305","author":"Lenard","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.pbb.2013.01.010_bb0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0028-3908(92)90147-H","article-title":"The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist","volume":"31","author":"Maj","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.01.010_bb9000","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1471-4892(01)00116-3","article-title":"Serotonergic targets in depression","volume":"2","author":"Middlemiss","year":"2002","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"10.1016\/j.pbb.2013.01.010_bb0120","first-page":"853","article-title":"Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors","volume":"295","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pbb.2013.01.010_bb0185","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.pbb.2008.02.020","article-title":"Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression","volume":"89","author":"Overstreet","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"issue":"5604","key":"10.1016\/j.pbb.2013.01.010_bb0125","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2013.01.010_bb0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"issue":"3\u20134","key":"10.1016\/j.pbb.2013.01.010_bb0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10571-005-3969-3","article-title":"The serotonin 1A receptor: a representative member of serotonin receptor family","volume":"25","author":"Pucadyil","year":"2005","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000119183","article-title":"Comparative effects of amitriptyline and amineptine in patients affected by anxious depression","volume":"31","author":"Rampello","year":"1995","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pbb.2013.01.010_bb0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(97)00115-5","article-title":"Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test","volume":"325","author":"Redrobe","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0924-977X(97)00073-4","article-title":"Clonidine potentiates the effects of 5-HT, 5-HT2A\/2C and 5-HT1A\/1B antagonists and 8-OH-DPAT in the mouse forced swimming test","volume":"8","author":"Redrobe","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0889-1591(02)00013-2","article-title":"Tryptophan, mood, and cognitive function","volume":"16","author":"Riedel","year":"2002","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pbb.2013.01.010_bb0160","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pbb.2005.08.003","article-title":"Antidepressant-like and antinociceptive-like actions of 4-(4\u2032-chlorophenyl)- 6-(4-methylphenyl)-2-hydrazinepyrimidine Mannich base in mice","volume":"82","author":"Rodrigues","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.01.010_bb0165","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0924-977X(99)00027-9","article-title":"Anxiety with depression: a treatment need","volume":"3","author":"Rouillon","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0170","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/mol.52.6.1056","article-title":"Antisense inhibition of 5-hydroxytriptamine 2A receptor induces an antidepressant-like effect in mice","volume":"52","author":"Sibille","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2013.01.010_bb0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(92)90296-G","article-title":"Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical betaadrenoceptors","volume":"219","author":"Simiand","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pbb.2013.01.010_bb0180","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/sj.npp.1301424","article-title":"Stimulation of the beta(3)-adrenoceptor as a novel treatment strategy for anxiety and depressive disorders","volume":"33","author":"Stemmelin","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2013.01.010_bb0190","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbr.2009.09.003","article-title":"Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress","volume":"206","author":"Stemmelin","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2013.01.010_bb0195","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1476-5381.1995.tb17205.x","article-title":"Expression of beta 3-adrenoceptor mRNA in rat brain","volume":"116","author":"Summers","year":"1995","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.pbb.2013.01.010_bb0200","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.pbb.2008.04.016","article-title":"Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats","volume":"90","author":"Ulak","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.01.010_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pbb.2010.02.006","article-title":"Involvement of serotonin receptor subtypes in the antidepressant-like effect of trim in the rat forced swimming test","volume":"95","author":"Ulak","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"issue":"22","key":"10.1016\/j.pbb.2013.01.010_bb5000","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/S0024-3205(03)00141-3","article-title":"5\u2013HT2A and 5\u2013HT2C receptors and their atypical regulation properties","volume":"72","author":"Van Oekelen","year":"2003","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.pbb.2013.01.010_bb0210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopsych.2003.11.016","article-title":"Decreased 5-HT1A receptor binding in amygdala of schizophrenia","volume":"55","author":"Yasuno","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.010_bb0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00431803","article-title":"Tryptophan depletion causes a rapid lowering of mood in normal males","volume":"87","author":"Young","year":"1985","journal-title":"Psychopharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:21:12Z","timestamp":1562631672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305713000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":42,"alternative-id":["S0091305713000142"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.01.010","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): An experimental study","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2013.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}